Valuation: Implanet SA

Market Cap 22.72M 25.46M 21.12M 19.21M 36.14M 2.41B 36.79M 254M 99.26M 1.26B 95.53M 93.51M 4.03B P/E 2024
-2.85x
P/E 2025 -5.8x
Enterprise Value 25.64M 28.72M 23.83M 21.67M 40.78M 2.72B 41.51M 286M 112M 1.42B 108M 106M 4.54B EV / Sales 2024
2x
EV / Sales 2025 2.23x
Free-Float
33.85%
Yield 2024 *
-
Yield 2025 -
1 day-5.44%
1 week-5.44%
Current month-6.62%
1 month-13.04%
3 months-15.97%
6 months-30.67%
Current year-24.74%
1 week 0.14
Extreme 0.142
0.19
1 month 0.14
Extreme 0.14
0.19
Current year 0.14
Extreme 0.14
0.29
1 year 0.14
Extreme 0.14
0.3
3 years 0.04
Extreme 0.035
0.45
5 years 0.04
Extreme 0.035
0.58
10 years 0.04
Extreme 0.035
56.8
Manager TitleAgeSince
Chief Executive Officer - 26/11/2012
Director of Finance/CFO - 31/08/2015
Chief Operating Officer - -
Director TitleAgeSince
Chairman 71 05/04/2011
Director/Board Member - 21/01/2013
Director/Board Member - 09/06/2014
Change 5-day change 1-year change 3-year change Capi.($)
-5.44%-5.44%-47.76%+144.12% 25.46M
+1.66%+6.28%-19.13%+15.20% 181B
+1.29%+8.77%+0.12%+32.64% 117B
+4.12%+5.87%-20.70%+13.71% 112B
+2.69%+4.34%-44.79%-7.80% 76.56B
+1.56%+6.24%+6.82%+80.66% 65.15B
+2.79%+2.37%+15.93%+68.64% 52.79B
+2.58%+6.02%+3.74%-25.10% 52.78B
+3.43%+6.63%-14.39%+28.39% 43.11B
+1.78%+2.32% - - 32.08B
Average +1.25%+4.62%-13.35%+38.94% 73.3B
Weighted average by Cap. +1.72%+5.70%-11.91%+23.25%

Financials

2024 2025
Net sales 9.41M 10.54M 8.74M 7.95M 14.96M 998M 15.23M 105M 41.09M 521M 39.55M 38.71M 1.67B 12.47M 13.97M 11.59M 10.55M 19.84M 1.32B 20.2M 139M 54.49M 691M 52.44M 51.33M 2.21B
Net income -4.37M -4.89M -4.06M -3.69M -6.94M -463M -7.07M -48.74M -19.07M -242M -18.36M -17.97M -773M -4.38M -4.91M -4.07M -3.7M -6.97M -465M -7.1M -48.92M -19.14M -243M -18.42M -18.03M -776M
Net Debt 4.57M 5.12M 4.25M 3.86M 7.27M 485M 7.4M 51.01M 19.96M 253M 19.21M 18.8M 809M 2.92M 3.27M 2.71M 2.46M 4.64M 309M 4.72M 32.54M 12.73M 161M 12.26M 12M 516M
Projected Income Statement - Annual - Implanet SA
Logo Implanet SA
Implanet SA designs, produces, and sells medical implants and devices used in orthopedic surgery. The group's products include spinal bracing systems, intersomatic cages, pins, suture threads, screws, anchors, etc. Net sales break down by activity as follows: - sale of implants and devices for spinal surgery (68.6%); - distribution of medical equipment (31.3%). Net sales are distributed geographically as follows: France (35.6%), the United States (30.8%) and other (33.6%).
Employees
49
Date Price Change Volume
16/10/26 €0.1492 -5.57% 35,612
15/10/26 €0.1580 -3.42% 88,830
14/10/26 €0.1636 -12.04% 375,242
13/10/26 €0.1860 +15.53% 449,700
12/10/26 €0.1610 +1.90% 45,388
  1. Stock Market
  2. Stocks
  3. ALIMP Stock